Financial information. Sensitive data transferred (if applicable) and applied restrictions or safeguards that fully take into consideration the nature of the data and the risks involved, such as for instance strict purpose limitation, access restrictions (including access only for staff having followed specialised training), keeping a record of access to the data, restrictions for onward transfers or additional security measures: The personal data transferred concern the following special categories of data: Any health, genetic and other sensitive data of Study Subjects as required by the Protocol, including the following:
1. Racial or ethnic origin, in accordance with the Agreement, the Protocol and informed consent form and in compliance with local applicable laws
2. Data related to health, such as without limitation: - Prior therapy, concomitant medication, sub-sequent therapy - Current medical conditions - Relevant medical history - Results of physical examination - Testing results, images and tissue samples/slides (e.g. laboratory testing / radiology testing / assessment of samples or slides derived from bone marrow biopsy)
3. Genetic data derived from Biological Samples The frequency of the transfer (e.g. whether the data is transferred on a one-off or continuous basis): On a continuous basis, as required for the performance of the Study and as set forth in the Agreement, Protocol and informed consent form and any written instructions issued by data importer. Nature of the processing: The processing involves for example collection, recording, organisation, filing, storage, adaptation or alteration, retrieval, disclosure by transmission, disclosure or any other form of provision, comparison or combination, restriction, erasure or destruction.
Financial information. 1. Declaration by the legal representative of the issuer or other duly authorised person attesting that the solo or consolidated annual accounts for the last three years have been approved by the competent bodies and that they have been published and filed they conform with the original. The interval between the closing date of the latest published annual accounts and the admission to listing decision may not be more than fifteen months.
2. Where it is not included in the document specified in points 1.03, a copy of the report of the statutory auditor or the statutory auditing company on the annual accounts on a solo or a consolidated basis, for the last of the three annual periods and, where they exist, for the two preceding years.
3. Where the closing date of the last of the annual accounts is more than 9 months before the date of the admission to listing decision, where not included in the document specified in point 1.03, an interim balance sheet and income statement of the issuer on a solo or a consolidated basis — drawn up on the basis of the formats in force for listed companies, fully audited and accompanied by explanatory notes — with reference to at least the 6 months subsequent to the closing date of the last annual accounts and compared with the corresponding period of the previous financial year. The interim balance sheet and income statement on a solo and a consolidated basis must (i) contain all the attachments prescribed by law and (ii) be accompanied by an explicit declaration by the legal representative of the issuer or other duly authorised person attesting that they have been approved by the competent bodies and that they conform with the original. With regard to the audits referred to in this point, Borsa Italiana may, in exceptional circumstances, accept partial statutory audits, whose scope must be agreed in advance with Borsa Italiana, provided all the information needed to evaluate the issuer and the instruments for which application for listing has been made is available.
4. Taking account of the planned date for the start of trading, Borsa Italiana may request a fully audited balance sheet and income statement for a period ending on a different date, which shall be more recent than those specified in points 3.03 and 3.04. With regard to the statutory audits referred to in this point, Borsa Italiana may, in exceptional circumstances, accept partial statutory audits, whose scope must be agreed in advance with Borsa Italiana, provid...
Financial information. 1. A copy of the latest annual report, or in the absence thereof, statements of the profits and losses and assets and liabilities for a period of less than one year, authenticated by the management company’s legal representative or other duly authorised person, audited by a statutory auditor or statutory auditing company. Where the interval between the closing date of the financial year and the admission to listing decision is more than seven months, a copy of the half-yearly report must be attached together with the opinion of the statutory auditor or the statutory auditing company. The interval between the closing date of the latest annual report on operations and the admission to listing decision may not be more than fourteen months.
2. In the case referred to in Article 2.2.34, paragraph 2, of the Rules has been granted, a copy of pro forma statements of the fund’s profits and losses and assets and liabilities. The report on the pro forma data prepared by a of statutory auditor or a statutory auditing company containing a statement prepared in accordance with the best applicable international standards the results of the checking activity on the reasonableness of the basic assumptions made in preparing the pro forma report, on the correct application of the methods used and on the appropriateness of the accounting policies adopted for the preparation of the document.